| Literature DB >> 23583972 |
Timothy L Hodgson1, Petroc Sumner, Dimitra Molyva, Ray Sheridan, Christopher Kennard.
Abstract
Making flexible associations between what we see and what we do is important for many everyday tasks. Previous work in patients with focal lesions has shown that the control of saccadic eye movements in such contexts relies on a network of areas in the frontal cerebral cortex. These regions are reciprocally connected with structures in the basal ganglia although the contribution of these sub-cortical structures to oculomotor control in complex tasks is not well understood. We report the performance of patients with idiopathic Parkinsons disease (PDs) in a test which required learning and switching between arbitrary cue-saccade rules. In Experiment 1 feedback was given following each response which reliably indicated which of the two possible rules was correct. PDs were slower to learn the first cue-saccade association presented, but did not show increased error or reaction time switch costs when switching between two rules within blocks. In a follow up experiment the feedback given by the computer was adjusted to be probabilistic such that executing a response based upon the "correct" rule only resulted in positive feedback on 80% of trials. Under these conditions patients were impaired in terms of response latencies and number of errors. In all conditions PDs showed multi-stepping/hypometria of saccades consistent with a motoric deficit in executing actions based on cognitive cues. The findings are consistent with a role for the nigrostriatal dopamine system in the reinforcement of saccade-response-outcome associations. Intact performance of PDs when associations are not stochastically reinforced suggests that striatal learning systems are complemented by cognitive representations of task rules which are unaffected in the early stages of PD.Entities:
Mesh:
Year: 2013 PMID: 23583972 PMCID: PMC3740233 DOI: 10.1016/j.neuropsychologia.2013.03.026
Source DB: PubMed Journal: Neuropsychologia ISSN: 0028-3932 Impact factor: 3.139
Patient details. Exp1=Simple Associative Task and Rule Switching Tasks completed. Exp1a=Simple Associative Task only completed. CX=Charing Cross Hospital recruitment; EX=Royal Devon and Exeter Hospital. H&Y=Hoen and Yahr sore; MMSE=Mini mental state assessment; NART=National Adult Reading Test errors;UPDRS=Unified Parkinsons Disease Rating Scale.
| 01 | Exp1 | CX | 72 | F | Sinemet CR; Pramipexole | 6 years | 13 (19) | 1.5 | 30 | 9 | 15 |
| 02 | Exp1 | CX | 66 | M | Sinemet CR | 7 years | 23 (33) | 3 | 29 | 19 | 14 |
| 03 | Exp1a | CX | 56 | M | Sinemet; Sinemet CR; Cabergoline | 9 years | 24 (34) | 3 | 23 | 5 | 13 |
| 04 | Exp1 | CX | 69 | M | Benhexol; Selegilin; | 10 years | 5 (7) | 1 | 30 | 8 | 15 |
| 05 | Exp1 | CX | 54 | F | Sinamet CR; Sinemet plus; pergoline | 5 years | 16 (23) | 2.5 | 30 | 3 | 15 |
| 06 | Exp1a | CX | 74 | M | Sinemet; Sinemet CR | 13 years | 19 (27) | 4 | 26 | 15 | 14 |
| 07 | Exp1 | CX | 63 | F | Sinemet; Pergolide | 8 years | 14 (20) | 2.5 | 25 | 12 | 17 |
| 08 | Exp1 | CX | 54 | F | Madopar; Selegiline; Propanolol | 6 years | 14 (20) | 2 | 28 | 21 | 12 |
| 09 | Exp1 | CX | 57 | M | Sinemet | 6 years | 15 (21) | 2.5 | 29 | 7 | 18 |
| 10 | Exp1 | CX | 45 | M | Benhexol; Cabergoline | 5 years | 11 (16) | 2 | 27 | 11 | 18 |
| 11 | Exp1 | CX | 61 | F | Sinemet; Benhexol | 1 years | 2 (3) | 1 | 30 | 8 | 22 |
| 12 | Exp1 | CX | 56 | F | Pramipexole | 6 years | 13 (19) | 1.5 | 30 | 20 | 18 |
| 13 | Exp1 | CX | 48 | M | Sinemet CR; Pergolide | 4 years | 26 (37) | 3 | 27 | 24 | 16 |
| 14 | Exp1a; Exp2 | EX | 74 | F | Madopar; Pramipexole | 7 years | 5 (7) | 1 | 30 | 14 | 15 |
| 15 | Exp1; Exp2 | EX | 71 | M | Madopar | 18 months | 8 (11) | 2 | 29 | 13 | 15 |
| 16 | Exp1 | EX | 74 | M | Selegiline; Pramipexole | 4 Years | 12.5 (18) | 2 | 29 | 9 | 15 |
| 17 | Exp1; Exp2 | EX | 72 | M | Pramiprexole; Sinemet | 6 years | 11 (16) | 2 | 27 | 5 | 12 |
| 18 | Exp1 | EX | 70 | F | Sinemet CR; Madopar | 16 years | 15 (21) | 2 | 30 | 5 | 13 |
| 19 | Exp2 | EX | 74 | M | Pramipexo | 1 year | 9 (13) | 2 | 27 | 5 | 15 |
| 20 | Exp2 | EX | 66 | M | Sinemet | 6 years | 11 (16) | 2 | 30 | 6 | 13 |
| 21 | Exp1a | EX | 79 | F | Sinemet; selegiline | 7 years | 11 (16) | 2.5 | 28 | 12 | 16 |
| 22 | Exp2 | EX | 65 | M | Pramipexole | 4 years | 15 (21) | 2.5 | 29 | 6 | 22 |
| 23 | Exp1 | EX | 71 | M | Madopar | 18 months | 11 (16) | 2.5 | 28 | 10 | 13 |
| 24 | Exp1; Exp2 | EX | 72 | F | Sinemet CR; Selegiline; Amantadine | 7–8 years | 11 (16) | 2 | 27 | 5 | 15 |
| 25 | Exp 2 | EX | 63 | M | Sinemet CR; pramipexole | 13 years | 11 (16) | 2 | 26 | 10 | 11 |
Fig. 1Schematic of typical trial sequence in the rule switching tasks. Arrows represent saccadic responses to left or right response box: (a) standard rule switching task (Experiment 1), in which positive/negative feedbacks reliably indicate the rule. (b) Probablistic rule switching task (Experiment 2) for which positive feedbacks occur with 80% likelihood when the optimal rule is used.
Fig. 2Errors and trials to learning criterion for non-switching blocks in Experiments 1 and 2 and the first rule change encountered in the rule switching condition of Experiment 1 (*Indicates significant difference between groups at p<0.05 or greater. n.s.=non-significant difference).
Fig. 3Errors and latencies in the two rule switching tasks plotted against trials after rule change for PDs and Controls. Trial “zero” represents the response on which the rule contingent post-response feedback was modified, such that “errors” represent responses correct according to the alternate rule: (a) Experiment 1 when feedback was 100% reliable. (b) Experiment 2 in which feedback only indicated the optimal rule with 80% validity.
Fig. 4Reward related negative priming effect on saccade response latencies in patients and controls. Responses were significantly slowed when saccades are cued back to the same location at which a negative feedback had been presented on the previous trial (difference between same and different direction trials following a negative feedback *p<0.001; n.s. indicates non-significant).